Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Sotonye Esedu Imadojemu, M.D.

Concepts (124)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Sarcoidosis620235072.750 Why?
Skin Diseases8202310652.350 Why?
Dermatology620228711.130 Why?
Granuloma420233130.960 Why?
Cosmetic Techniques320131330.880 Why?
Moral Obligations22013980.840 Why?
Informed Consent220139880.560 Why?
Patients220138900.560 Why?
Yellow Nail Syndrome1201520.550 Why?
Fluconazole120151450.510 Why?
Triamcinolone Acetonide120151010.500 Why?
Pilomatrixoma12014230.480 Why?
Hair Diseases12014720.460 Why?
Skin Pigmentation120132810.390 Why?
Scalp120143760.390 Why?
Antifungal Agents120157220.380 Why?
Necrobiosis Lipoidica22019120.350 Why?
Ethics, Medical120137930.310 Why?
Face120139850.300 Why?
Cyclosporine220207810.300 Why?
Anti-Inflammatory Agents1201517770.260 Why?
Patient Satisfaction1201333820.190 Why?
Chronic Disease3202391330.190 Why?
Erythema Nodosum12020300.190 Why?
Necrobiotic Xanthogranuloma1202090.190 Why?
Acute Generalized Exanthematous Pustulosis12020130.180 Why?
Granuloma Annulare12019270.170 Why?
Lymphatic Diseases120203240.160 Why?
Skin3202343240.160 Why?
Dermatomyositis220172230.160 Why?
Physicians1201645390.150 Why?
Paraproteinemias120202460.150 Why?
Education, Distance120202500.140 Why?
Dermatitis Herpetiformis12016260.140 Why?
Skin Neoplasms2201656320.130 Why?
Hair Follicle120172080.130 Why?
Injections, Intralesional120152760.120 Why?
Pemphigoid, Bullous120161090.120 Why?
Skin Care12013490.110 Why?
Lactation120164100.110 Why?
Alopecia120173760.110 Why?
Drug Eruptions120162950.110 Why?
Rejuvenation12013870.110 Why?
Humans2520237393980.110 Why?
Dermatologic Agents120162740.110 Why?
Career Choice120167420.090 Why?
Education, Medical1202017120.080 Why?
Diagnosis, Differential12023129480.080 Why?
Autoimmune Diseases2201621160.070 Why?
Goals120127020.070 Why?
Antigens, CD1201740240.070 Why?
Sinusitis120159170.070 Why?
Immunotherapy1202143910.070 Why?
Drug Therapy, Combination1201564780.060 Why?
CD4-Positive T-Lymphocytes1201743740.060 Why?
Counseling1201215260.060 Why?
Immunoglobulin G1201645220.060 Why?
CD8-Positive T-Lymphocytes1201744240.060 Why?
Patient Protection and Affordable Care Act1201312060.060 Why?
Telemedicine1202028440.060 Why?
Lupus Erythematosus, Systemic2201620910.050 Why?
Pregnancy Complications1201628670.050 Why?
Retrospective Studies52020766310.050 Why?
Middle Aged920202128630.050 Why?
Diabetes Mellitus1201957020.050 Why?
Administration, Cutaneous120227080.050 Why?
Prognosis12020289010.040 Why?
Coronary Vessels1201130970.040 Why?
Antibodies, Monoclonal1201692590.040 Why?
Methylprednisolone120203880.040 Why?
Endothelial Cells1201134350.040 Why?
CD4-CD8 Ratio120171120.040 Why?
Stem Cells1201135660.040 Why?
Faculty120203760.040 Why?
Randomized Controlled Trials as Topic1201398120.040 Why?
Female1020203788530.040 Why?
Obesity12019126430.040 Why?
Male820203490220.030 Why?
Ultraviolet Therapy12016810.030 Why?
Thyroid Diseases120193780.030 Why?
Scleroderma, Localized12016780.030 Why?
Pemphigus120161050.030 Why?
Antiphospholipid Syndrome120161730.030 Why?
Sex Distribution1201922960.030 Why?
Adult620202133940.030 Why?
Antineoplastic Agents12016136350.030 Why?
Age Distribution1201929040.030 Why?
Administration, Oral1202039090.030 Why?
Quality of Life12013126400.030 Why?
Scleroderma, Systemic120163120.030 Why?
Case-Control Studies22020216940.030 Why?
Drug Administration Schedule1202049350.030 Why?
Dyslipidemias120198510.030 Why?
Neck120166910.020 Why?
Glucocorticoids1202021000.020 Why?
Head120168760.020 Why?
Lung Diseases, Interstitial120178040.020 Why?
Fibrosis1201620240.020 Why?
Cross-Sectional Studies22020247140.020 Why?
Aged520201626980.020 Why?
Students, Medical1202018500.020 Why?
Pilot Projects1202082750.020 Why?
Curriculum1202035750.020 Why?
Massachusetts1202086690.020 Why?
Inflammation22017105340.020 Why?
Clinical Trials as Topic1202278970.020 Why?
United States12013695730.020 Why?
Comorbidity12019103620.020 Why?
Treatment Outcome22020626930.010 Why?
Severity of Illness Index12020155110.010 Why?
Multiple Myeloma1202051470.010 Why?
Arthritis, Rheumatoid1201636890.010 Why?
Pandemics1202082740.010 Why?
Hypertension1201984310.010 Why?
Endothelium, Vascular1201144540.010 Why?
Time Factors12020400500.010 Why?
Melanoma1201654460.010 Why?
Cohort Studies12020403890.010 Why?
Pregnancy12016290020.010 Why?
Aged, 80 and over12019576500.010 Why?
Young Adult12019562550.010 Why?
Risk Factors12019719740.010 Why?
Adolescent12019854050.010 Why?
Animals120161683680.000 Why?
Imadojemu's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (124)
Explore
_
Co-Authors (12)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.